Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,242 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $414.10 | 9 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $284.46 | 5 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $206.13 | 6 | $0 (2024) |
| ABBVIE INC. | $125.00 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $97.40 | 1 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $89.25 | 5 | $0 (2023) |
| Ardelyx, Inc. | $25.27 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $696.67 | 14 | Otsuka America Pharmaceutical, Inc. ($276.01) |
| 2023 | $273.29 | 9 | Otsuka America Pharmaceutical, Inc. ($138.09) |
| 2022 | $211.36 | 2 | ACADIA Pharmaceuticals Inc ($113.96) |
| 2021 | $60.29 | 3 | ACADIA Pharmaceuticals Inc ($60.29) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/28/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: Neuropsychiatry | ||||||
| 09/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.73 | General |
| Category: Neuropsychiatry | ||||||
| 08/22/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Neuropsychiatry | ||||||
| 07/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: Neuropsychiatry | ||||||
| 05/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $114.23 | General |
| Category: Neuropsychiatry | ||||||
| 05/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: PSYCHIATRY | ||||||
| 04/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: PSYCHIATRY | ||||||
| 04/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: PSYCHIATRY | ||||||
| 03/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $111.92 | General |
| Category: PSYCHIATRY | ||||||
| 03/22/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $110.21 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 02/29/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $111.92 | General |
| Category: NEUROLOGY | ||||||
| 01/26/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: NEUROLOGY | ||||||
| 12/01/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Central Nervous System | ||||||
| 10/06/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: NEUROLOGY | ||||||
| 08/31/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: NEUROLOGY | ||||||
| 07/26/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $101.88 | General |
| Category: NEUROLOGY | ||||||
| 04/07/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Central Nervous System | ||||||
| 03/03/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Central Nervous System | ||||||
| 01/25/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $45.95 | General |
| Category: Neuropsychiatry | ||||||
| 01/23/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Central Nervous System | ||||||
| 01/06/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Central Nervous System | ||||||
| 10/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $97.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/15/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $113.96 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 544 | 1,333 | $178,665 | $86,415 |
| 2022 | 5 | 585 | 1,514 | $209,575 | $89,812 |
| 2021 | 5 | 610 | 1,678 | $240,275 | $106,713 |
| 2020 | 6 | 690 | 1,940 | $273,265 | $123,404 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 172 | 547 | $79,315 | $39,916 | 50.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 122 | 470 | $51,700 | $23,481 | 45.4% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 105 | 122 | $26,230 | $13,060 | 49.8% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 73 | 75 | $12,375 | $6,715 | 54.3% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 61 | 108 | $7,560 | $2,661 | 35.2% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 11 | 11 | $1,485 | $583.00 | 39.3% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 214 | 772 | $111,940 | $46,872 | 41.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 118 | 428 | $47,080 | $20,408 | 43.3% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 116 | 144 | $30,960 | $13,707 | 44.3% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 78 | 81 | $13,365 | $6,036 | 45.2% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 59 | 89 | $6,230 | $2,789 | 44.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 223 | 1,017 | $147,465 | $65,066 | 44.1% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 134 | 181 | $38,915 | $17,480 | 44.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 118 | 315 | $34,650 | $15,416 | 44.5% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2021 | 78 | 81 | $13,365 | $6,119 | 45.8% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 57 | 84 | $5,880 | $2,632 | 44.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 224 | 1,048 | $151,960 | $68,944 | 45.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 152 | 472 | $51,920 | $22,951 | 44.2% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 152 | 205 | $44,075 | $20,160 | 45.7% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2020 | 84 | 92 | $15,180 | $7,059 | 46.5% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2020 | 62 | 104 | $7,280 | $3,016 | 41.4% |
| 99356 | Prolonged inpatient or observation hospital service first hour | Facility | 2020 | 16 | 19 | $2,850 | $1,274 | 44.7% |
About Tara Sanabria
Tara Sanabria is a Family healthcare provider based in Monroe, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2019. The National Provider Identifier (NPI) number assigned to this provider is 1215581202.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tara Sanabria has received a total of $1,242 in payments from pharmaceutical and medical device companies, with $696.67 received in 2024. These payments were reported across 28 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($1,242).
As a Medicare-enrolled provider, Sanabria has provided services to 2,429 Medicare beneficiaries, totaling 6,465 services with total Medicare billing of $406,344. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Monroe, CT
- Active Since 07/29/2019
- Last Updated 07/29/2019
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215581202
Products in Payments
- NUPLAZID (Drug) $284.46
- NUEDEXTA (Drug) $258.30
- INGREZZA (Drug) $206.13
- REXULTI (Drug) $155.80
- FARXIGA (Drug) $97.40
- AUSTEDO (Drug) $68.98
- IBSRELA (Drug) $25.27
- Austedo XR (Drug) $20.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Monroe
Mr. Tavell Kindall, Fnp-Bc, FNP-BC
Family — Payments: $129,737
Lane Judge, Fnp-C, FNP-C
Family — Payments: $37,930
Gabrielle Nicolle
Family — Payments: $11,324
Mrs. Jereta Lawrence, Fnp-C, FNP-C
Family — Payments: $11,016
Mrs. Catherine Midyett, Fnp, FNP
Family — Payments: $10,122
Kate Breiner, Np, NP
Family — Payments: $7,853